Edition:
United States

Biocartis Group NV (BCART.BR)

BCART.BR on Brussels Stock Exchange

12.40EUR
9:34am EDT
Change (% chg)

€0.18 (+1.47%)
Prev Close
€12.22
Open
€12.40
Day's High
€12.50
Day's Low
€12.26
Volume
48,321
Avg. Vol
95,430
52-wk High
€15.00
52-wk Low
€9.51

Select another date:

Thu, Mar 1 2018

BRIEF-Biocartis FY Total Operating Income Up At 23.1 Million Euros

* FY TOTAL OPERATING INCOME: EQUALED EUR 23.1M IN 2017 COMPARED TO EUR 13.8M IN 2016,

BRIEF-The EU Provides Biocartis With Up To 24 Million Euros Debt For Infectious Disease Projects

* REG-BIOCARTIS GROUP NV: EUROPEAN UNION PROVIDES BIOCARTIS WITH UP TO EUR 24M DEBT FINANCING FACILITY FOR INFECTIOUS DISEASE PROJECTS

BRIEF-Biocartis And Amgen Sign New Agreement

* REG-BIOCARTIS GROUP NV: BIOCARTIS AND AMGEN SIGN NEW COMPANION DIAGNOSTIC AGREEMENT FOR NOVEL ONCOLOGY COMPOUND

BRIEF-Biocartis And Amgen Sign Companion Diagnostic Agreement For Idylla(Tm) RAS Biomarker Tests

* BIOCARTIS AND AMGEN SIGN COMPANION DIAGNOSTIC AGREEMENT FOR IDYLLA(TM) RAS BIOMARKER TESTS

BRIEF-Biocartis Raises 80 Million Dollars

* ANNOUNCED ON TUESDAY THAT IT RAISED EUR 80 MILLION IN GROSS PROCEEDS

BRIEF-Bookrunner says Biocartis Group deal upsized to 80 mln euros From 60 mln euros base deal size‍​

* BLOCK TRADE- BIOCARTIS GROUP NV: BOOKRUNNER SAYS DEAL UPSIZED TO 80 MILLION EUROS FROM 60 MILLION EUROS BASE DEAL SIZE‍​

BRIEF-Biocartis Share Offering Of Up To About 8.9 mln Shares ‍​- bookrunner

* SAYS OFFERING DEAL SIZE ABOUT 60 MILLION EUROS‍​ Further company coverage:

BRIEF-Biocartis Launches Equity Placement

* REG-BIOCARTIS GROUP NV: BIOCARTIS LAUNCHES EQUITY PLACEMENT

BRIEF-Biocartis Group Launches Liquid Biopsy Tests with Merck

* ‍TESTS DEVELOPED UNDER PARTNERSHIP WITH MERCK KGAA, DARMSTADT, GERMANY​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: